The BOD had plenty of options to negotiate with Pfizer without...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 547 Last

Share
Profile

Follow
asanque

204 Posts.

18

16/06/22

13:01

Post #: 62034868
Share

Originally posted by bajachris88: ↑

I don't feel it is right to criticise the BOD, as there may be an element of genius to these current events.

All those people saying "do the BOD think we're idiots; as if we're going to accept 11.5c!" etc.... what if the BOD was counting on you rejecting that price all along? ... Specifically, the BOD knew that 11.5c wouldn't be accepted, but played the 'right cards' so that the BOD could secure the addition funding from Pfizer, and commence a bidding game, given the opportunity presented itself?

And look at the outcomes; the game appears to be progressing well. Progressing is the key word, as the end-state isn't visible yet which means there is so much prospect still left.

Here's the progress so far; we got that additional funding (no need for CR), and the bid has now shifted from 11.5c to 20.7 (pending the report), and no final offer ceiling is visible yet. The BOD know its the SH that get the final say of what is the right value for the consensus, and this has always been the case through the voting requirement. Thus, how could the BOD ever shaft the majority of SH in the first place? BOD luring the big pharma fish with crumbs ...

When all is said and done, there is a great possibility that we will be well away from the original 11.5c offer; perhaps a thanks to the BOD may be better suited haha. I suggest all SH should attempt to rationalise this situation by considering the decision making processes deeper than just the surface of the water.

There's perception, psychology and strategy at play; the reaction of SH to the face-value of recent announcements is perhaps the desired reaction of the BOD to pressure Pfizer to lift their game by a long (nonetheless incremental) stretch, given Big Pharma need to win the hearts/minds of the voters.

My 2c...

Expand

The BOD had plenty of options to negotiate with Pfizer without embarrassing themselves by continually recommending low ball offers to shareholders.

Just reeks of taking the easy option.

RAP Price at posting: 16.5¢ Sentiment: Hold Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

GTR

GTI extends uranium mineralisation at Lo Hema through development drilling

3 stocks with antimony news on Thursday

CU6

Clarity progresses SECuRE trial with positive safety results

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

CHN

Chalice jumps on Putin nickel export ban threat – but then there's bad news